bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii) has been researched along with Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Christian, MC | 1 |
| Perez-Soler, R; Sugarman, SM | 1 |
| al-Baker, S; Francis, K; Khokhar, AR; Lautersztain, J; Lopez-Berestein, G; Macias-Kiger, D; Perez-Soler, R; Raber, MN | 1 |
2 review(s) available for bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii) and Neoplasms
| Article | Year |
|---|---|
The current status of new platinum analogs.
Topics: Animals; Antineoplastic Agents; Carboplatin; Chemistry, Pharmaceutical; Cyclobutanes; Drugs, Investigational; Forecasting; Humans; Neoplasms; Organoplatinum Compounds; Oxaliplatin | 1992 |
Liposomes in the treatment of malignancy: a clinical perspective.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Antigens, Neoplasm; Antineoplastic Agents; Clinical Trials as Topic; Doxorubicin; Drug Carriers; Drug Evaluation; Drug Screening Assays, Antitumor; Humans; Immunotherapy; Liposomes; Macrophage Activation; Macrophages; Melanoma-Specific Antigens; Neoplasm Proteins; Neoplasms; Organoplatinum Compounds; Phosphatidylethanolamines; Quinazolines; Treatment Outcome | 1992 |
1 other study(ies) available for bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii) and Neoplasms
| Article | Year |
|---|---|
Phase I clinical and pharmacological study of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II).
Topics: Antineoplastic Agents; Drug Carriers; Drug Evaluation; Female; Hemoglobins; Humans; Leukocyte Count; Liposomes; Male; Neoplasms; Organoplatinum Compounds; Platelet Count | 1990 |